4
Changes in Ownership
Estrella Immunopharma, Inc. Filed Acc 0001996255-26-000004
CEO acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Liu Cheng · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-25 | Exercise or conversion : show line 1 in the form | +100,000 | $0.82 | $81,500 | 397,437 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-25 | Exercise or conversion : show line 2 in the form Incentive Stock Option | +100,000 | 900,000 | D |
Loading xslF345X06/primary_doc.xml…